Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Melissa McAlonis-Downes
Affiliation
Ludwig Institute for Cancer Research
ORCID
Career Start Year
2003
Papers
29
H Index
23
Expertise
CM4AI Collaborator
Prashant Mali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37996528
Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation.
Nat Neurosci
2024
34890975
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures.
Biomaterials
2022
36454749
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of <i>C9orf72</i> disease.
Proc Natl Acad Sci U S A
2022
34083786
Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTB.
Nat Neurosci
2021
34488813
Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation.
Mol Neurodegener
2021
32325059
ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.
Neuron
2020
31873312
Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS.
Nat Med
2020
32284607
Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72.
Nat Neurosci
2020
30747709
Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis.
Elife
2019
31092730
An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosis.
JCI Insight
2019
30344044
ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.
Neuron
2018
28247063
Misfolded SOD1 is not a primary component of sporadic ALS.
Acta Neuropathol
2017
28357566
Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
Acta Neuropathol
2017
27112497
Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs.
Neuron
2016
25801706
Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.
Neuron
2015
26621731
Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS.
Proc Natl Acad Sci U S A
2015
26108367
Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.
Acta Neuropathol Commun
2015
23486940
Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
J Neurosci
2013
24170860
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
Proc Natl Acad Sci U S A
2013
24170856
C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice.
Proc Natl Acad Sci U S A
2013
23382207
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43.
Proc Natl Acad Sci U S A
2013
22560226
Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS.
Cell Metab
2012
22726834
Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.
Neuron
2012
21779368
Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset.
PLoS One
2011
19251638
Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice.
Proc Natl Acad Sci U S A
2009
18492803
Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.
Proc Natl Acad Sci U S A
2008
16878173
Antisense oligonucleotide therapy for neurodegenerative disease.
J Clin Invest
2006
16802286
Progressive spinal axonal degeneration and slowness in ALS2-deficient mice.
Ann Neurol
2006
14655997
Estrous cycle and ovarian changes in a rat mammary carcinogenesis model after irradiation, tamoxifen chemoprevention, and aging.
Comp Med
2003
1 - 29 of 29
Column Actions
Search
Recommended Authors
Mathieu Bourdenx
University College London, UK Dementia Research Institute
Career Start Year
2013
Number of shared co-authors
0
Michael E Ward
National Institute of Neurological, National Institutes of Health (NIH)
Career Start Year
2011
Number of shared co-authors
0
Nima Dolatabadi
The Scripps Research Institute
Career Start Year
2010
Number of shared co-authors
0
Sue-Ann Mok
University of Alberta
Career Start Year
2007
Number of shared co-authors
0
Nicolas Casadei
Institute of Medical Genetics and Applied Genomics, University of Tubingen
Career Start Year
2007
Number of shared co-authors
0
Mary H Wertz
Broad Institute, Picower Institute for Learning and Memory
Career Start Year
2007
Number of shared co-authors
0
Vivek Swarup
David Geffen School of Medicine, University of California los angeles
Career Start Year
2007
Number of shared co-authors
0
Laura Ru??
Department of Pharmaceutical and Pharmacological Sciences
Career Start Year
2007
Number of shared co-authors
0
Kelly E Glajch
Neurodegenerative Diseases Research Unit
Career Start Year
2006
Number of shared co-authors
2
Carolina Ceballos-Diaz
Center for Translational Research in Neurodegenerative Disease, University of Florida
Career Start Year
2006
Number of shared co-authors
0
Merina Varghese
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai
Career Start Year
2005
Number of shared co-authors
0
Karen N McFarland
Center for Translational Research in Neurodegenerative Disease, University of Florida
Career Start Year
2005
Number of shared co-authors
0
Gaia Skibinski
Center for Systems and Therapeutics, J. David Gladstone Institutes
Career Start Year
1999
Number of shared co-authors
0
Aaron D Gitler
Stanford University School of Medicine
Career Start Year
1999
Number of shared co-authors
1
Li Gan
Helen and Robert Appel Alzheimer's Disease Research Institute
Career Start Year
1999
Number of shared co-authors
0
Giovanni Coppola
David Geffen School of Medicine, University of California los angeles
Career Start Year
1999
Number of shared co-authors
0
Sami J Barmada
University of Michigan ann arbor
Career Start Year
1997
Number of shared co-authors
0
Mimoun Azzouz
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year
1996
Number of shared co-authors
1
Giovanni Manfredi
Brain and Mind Research Institute
Career Start Year
1991
Number of shared co-authors
0
Cathleen Lutz
JAX Center for Precision Genetics
Career Start Year
1990
Number of shared co-authors
0
Eric J Huang
University of California san francisco
Career Start Year
1990
Number of shared co-authors
2
Lisa M Ellerby
Buck Institute for Research on Aging
Career Start Year
1990
Number of shared co-authors
0
William T Dauer
Peter O'Donnell Jr. Brain Institute
Career Start Year
1988
Number of shared co-authors
0
Valina L Dawson
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Career Start Year
1988
Number of shared co-authors
0
Steven Finkbeiner
J. David Gladstone Institutes
Career Start Year
1988
Number of shared co-authors
2
Jonathan D Cooper
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year
1987
Number of shared co-authors
2
Ted M Dawson
Johns Hopkins University School of Medicine
Career Start Year
1983
Number of shared co-authors
0
Pamela J Shaw
Sheffield Institute for Translational Neuroscience, University of Sheffield
Career Start Year
1983
Number of shared co-authors
2
Steven M Hersch
Inc. University Avenue
Career Start Year
1980
Number of shared co-authors
0
Virginia M-Y Lee
Perelman School of Medicine at the University of Pennsylvania
Career Start Year
1977
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Ying Sun
Co-authored papers
4
Leonard Petrucelli
Co-authored papers
3
Gene W Yeo
University of California
Co-authored papers
3
Tania F Gendron
Co-authored papers
3
Xiang-Dong Fu
Co-authored papers
3
James D Berry
Sean M Healey & AMG Center for ALS, Massachusetts General Hospital
Co-authored papers
1
Michael Hu
University of California San Diego
Co-authored papers
1
Alysson R Muotri
Department of Pediatrics/Rady Children's Hospital, University of California San Diego
Co-authored papers
1
Jon D Larson
NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
1
Laura Ferraiuolo
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Co-authored papers
1
Amy E Taylor
Co-authored papers
1
Robert J Wechsler-Reya
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
1
Scott R VandenBerg
University of California san francisco
Co-authored papers
1
Prashant Mali (CM4AI)
University of California San Diego
Co-authored papers
1
Daniella McDonald
University of California San Diego
Co-authored papers
1
Kyle Ford
University of California San Diego
Co-authored papers
1
Xin Yi Lei
University of California San Diego
Co-authored papers
1
Thomas D Glenn
Howard Hughes Medical Institute and Salk Institute for Biological Studies
Co-authored papers
1
Jessica M Rusert
University of California San Diego
Co-authored papers
1
Krystal Mach
University of California San Diego
Co-authored papers
1
Huilin Zhou
Co-authored papers
1
Lawrence S B Goldstein
university of california san diego
Co-authored papers
1
1 - 22